Second time the charm for Pfizer’s Epogen biosimilar in US
An advisory committee has recommended approval of Retacrit in the US after Pfizer addressed manufacturing and clinical concerns from its first submission in 2015.
Archives for May 29, 2017
40 in, 200 out: Novartis hires and fires in New Jersey
Swiss-headquartered Novartis Pharmaceuticals plans to add 40 positions to its manufacturing facility in Morris Plains, New Jersey, to focus on cell therapies.
Lithuania's Biotechpharma jumps on the 2,000L single-use seed train
Lithuanian CDMO Biotechpharma has completed a €15m ($16.7m) expansion adding more than 2,500L of single-use bioreactor capacity.